IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2020 Holdings

Filed 2020-11-16 | 11 holdings | $199.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$182.4M643,00091.3%
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$16.7M4,861,0008.4%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$132.3K928,1000.1%
Alkermes PLC(ALKS)SHSG01767105$129.7K7,825,0000.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$126.3K14,040,0000.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$91.3K797,7400.0%
Innoviva Inc(INVA)COM45781M101$67.0K6,414,0000.0%
Mersana Therapeutics IncCOM59045L106$52.8K2,837,0000.0%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$49.8K1,201,0000.0%
Regulus Therapeutics IncCOM NEW75915K200$9511,851,8510.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$1661,0000.0%